NCT00842114View on ClinicalTrials.gov

Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL)

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Non-Hodgkin's Lymphoma
Interventions
BIOLOGICAL

R+CVP+IFN

Immunochemotherapy

Trial Locations (1)

28006

Hospital Universitario de La Princesa, Madrid

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Fundación Leucemia y Linfoma, Spain

OTHER

NCT00842114 - Rituximab and CVP Plus Interferon for Follicular Non Hodgkins Lymphoma (NHL) | Biotech Hunter | Biotech Hunter